Kensey Nash Corp (NASDAQ:KNSY)

CAPS Rating: 2 out of 5

The Company provides a range of products in the field of resorbable biomaterials and endovascular devices in endovascular and orthopaedic markets.

Recs

1
Player Avatar bunker72070 (20.70) Submitted: 10/21/2006 9:27:35 AM : Underperform Start Price: $30.37 KNSY Score: -24.17

Continued earnings misses and failure to meet expectations will continue to pressure stock. Managemtn change would be viewed as a major positive and would cause me to change my opinion.

Report this Post 2 Comments
Member Avatar born2befly (< 20) Submitted: 8/31/2007 6:17:33 PM
Recs: 0

Management change is a must, they aren't looking to make profits, they are just there for themselves.

Report this Post
Member Avatar advanzio (63.52) Submitted: 12/4/2007 1:28:23 PM
Recs: 0

I agree. I just dumped my shares. Too many misses. I hung in for quite a while.

Report this Post

Featured Broker Partners


Advertisement